These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Detection of amyloid beta aggregates in the brain of BALB/c mice after Chlamydia pneumoniae infection. Boelen E; Stassen FR; van der Ven AJ; Lemmens MA; Steinbusch HP; Bruggeman CA; Schmitz C; Steinbusch HW Acta Neuropathol; 2007 Sep; 114(3):255-61. PubMed ID: 17581756 [TBL] [Abstract][Full Text] [Related]
3. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Güntert A; Döbeli H; Bohrmann B Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022 [TBL] [Abstract][Full Text] [Related]
4. Deposition of lactoferrin in fibrillar-type senile plaques in the brains of transgenic mouse models of Alzheimer's disease. Wang L; Sato H; Zhao S; Tooyama I Neurosci Lett; 2010 Sep; 481(3):164-7. PubMed ID: 20599473 [TBL] [Abstract][Full Text] [Related]
5. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T; Kiliaan AJ; Kadish I Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076 [TBL] [Abstract][Full Text] [Related]
7. Viral-induced inflammation is accompanied by beta-amyloid plaque reduction in brains of amyloid precursor protein transgenic Tg2576 mice. Stahl T; Reimers C; Johne R; Schliebs R; Seeger J Eur J Neurosci; 2006 Oct; 24(7):1923-34. PubMed ID: 17067295 [TBL] [Abstract][Full Text] [Related]
8. Infiltration of the brain by pathogens causes Alzheimer's disease. Itzhaki RF; Wozniak MA; Appelt DM; Balin BJ Neurobiol Aging; 2004; 25(5):619-27. PubMed ID: 15172740 [TBL] [Abstract][Full Text] [Related]
9. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease. Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749 [TBL] [Abstract][Full Text] [Related]
10. The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice. Lee JY; Friedman JE; Angel I; Kozak A; Koh JY Neurobiol Aging; 2004; 25(10):1315-21. PubMed ID: 15465629 [TBL] [Abstract][Full Text] [Related]
11. Aurones serve as probes of beta-amyloid plaques in Alzheimer's disease. Ono M; Maya Y; Haratake M; Ito K; Mori H; Nakayama M Biochem Biophys Res Commun; 2007 Sep; 361(1):116-21. PubMed ID: 17644062 [TBL] [Abstract][Full Text] [Related]
12. Type-specific evolution of amyloid plaque and angiopathy in APPsw mice. Harigaya Y; Tomidokoro Y; Ikeda M; Sasaki A; Kawarabayashi T; Matsubara E; Kanai M; Saido TC; Younkin SG; Shoji M Neurosci Lett; 2006 Feb; 395(1):37-41. PubMed ID: 16298484 [TBL] [Abstract][Full Text] [Related]
13. Regression stage senile plaques in the natural course of Alzheimer's disease. Oide T; Kinoshita T; Arima K Neuropathol Appl Neurobiol; 2006 Oct; 32(5):539-56. PubMed ID: 16972888 [TBL] [Abstract][Full Text] [Related]
14. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Garcia-Alloza M; Robbins EM; Zhang-Nunes SX; Purcell SM; Betensky RA; Raju S; Prada C; Greenberg SM; Bacskai BJ; Frosch MP Neurobiol Dis; 2006 Dec; 24(3):516-24. PubMed ID: 17029828 [TBL] [Abstract][Full Text] [Related]
15. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice. Dudal S; Krzywkowski P; Paquette J; Morissette C; Lacombe D; Tremblay P; Gervais F Neurobiol Aging; 2004 Aug; 25(7):861-71. PubMed ID: 15212840 [TBL] [Abstract][Full Text] [Related]
16. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease. Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner. Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918 [TBL] [Abstract][Full Text] [Related]
18. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models. Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827 [TBL] [Abstract][Full Text] [Related]
19. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease. Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398 [TBL] [Abstract][Full Text] [Related]
20. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Ikonomovic MD; Uryu K; Abrahamson EE; Ciallella JR; Trojanowski JQ; Lee VM; Clark RS; Marion DW; Wisniewski SR; DeKosky ST Exp Neurol; 2004 Nov; 190(1):192-203. PubMed ID: 15473992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]